HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In71, an Enterobacter cloacae blaVIM-1-carrying integron related to In70.2 from Italian Pseudomonas aeruginosa isolates: a SENTRY Antimicrobial Surveillance Program report.

Abstract
An Enterobacter cloacae strain showing decreased susceptibility to carbapenems was isolated from a blood culture of a patient hospitalized in Genoa, Italy, and screened for the presence of metallo-beta-lactamase (MBL) genes as part of the SENTRY Antimicrobial Surveillance Program. A bla(VIM-1)-carrying integron named In71 nearly identical to In70.2 reported in Pseudomonas aeruginosa strains isolated from various Italian cities since 2001 was identified in this strain. Interestingly, the In71 did not carry aadA1 nor possess the ISPa7 usually found in the P. aeruginosa integron In70.2. Mobilization of MBL genes from P. aeruginosa to members of the Enterobacteriaceae family is very worrisome because the rapid and wide dissemination of these potent antimicrobial resistance mechanisms could jeopardize the clinical use of carbapenems for the treatment of multidrug-resistant Enterobacteriaceae infections.
AuthorsMariana Castanheira, Hélio S Sader, Ronald N Jones, Eugenio Debbia, Renata C Picão, Ana C Gales
JournalMicrobial drug resistance (Larchmont, N.Y.) (Microb Drug Resist) Vol. 13 Issue 2 Pg. 130-4 ( 2007) ISSN: 1076-6294 [Print] United States
PMID17650966 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Carbapenems
  • beta-Lactamases
Topics
  • Anti-Bacterial Agents (pharmacology)
  • Carbapenems (pharmacology)
  • Drug Resistance, Multiple, Bacterial (genetics)
  • Enterobacter cloacae (genetics)
  • Genes, Bacterial
  • Integrons
  • Microbial Sensitivity Tests
  • Phenotype
  • Population Surveillance
  • Pseudomonas aeruginosa (enzymology, genetics, isolation & purification)
  • beta-Lactamases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: